KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Capital Leases (2016 - 2019)

Encompass Health (EHC) has disclosed Capital Leases for 10 consecutive years, with $384.1 million as the latest value for Q4 2019.

  • For Q4 2019, Capital Leases rose 45.6% year-over-year to $384.1 million; the TTM value through Dec 2019 reached $384.1 million, up 45.6%, while the annual FY2019 figure was $384.1 million, 45.6% up from the prior year.
  • Capital Leases hit $384.1 million in Q4 2019 for Encompass Health, up from $263.8 million in the prior quarter.
  • Across five years, Capital Leases topped out at $384.1 million in Q4 2019 and bottomed at $82.1 million in Q3 2015.
  • Average Capital Leases over 5 years is $244.0 million, with a median of $277.2 million recorded in 2017.
  • Year-over-year, Capital Leases skyrocketed 243.24% in 2016 and then fell 3.37% in 2017.
  • Encompass Health's Capital Leases stood at $288.2 million in 2015, then dropped by 3.09% to $279.3 million in 2016, then fell by 2.79% to $271.5 million in 2017, then decreased by 2.84% to $263.8 million in 2018, then surged by 45.6% to $384.1 million in 2019.
  • According to Business Quant data, Capital Leases over the past three periods came in at $384.1 million, $263.8 million, and $271.5 million for Q4 2019, Q4 2018, and Q4 2017 respectively.